Clinical Trials Directory

Trials / Sponsors / Y-mAbs Therapeutics

Y-mAbs Therapeutics

Industry · 15 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
TerminatedPhase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed o
Non-hodgkin Lymphoma
Phase 12025-04-21
RecruitingGD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
SCLC, Malignant Melanoma, Sarcoma
Phase 12022-11-17
Withdrawn177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malig
Leptomeningeal Metastasis, Solid Tumor, Adult
Phase 1 / Phase 22022-08-31
TerminatedA Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
AML, Childhood
Phase 12022-05-25
Withdrawn131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma
DIPG
Phase 12022-03-01
WithdrawnNaxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of P
Neuroblastoma
Phase 22021-12-02
TerminatedNaxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
Neuroblastoma Recurrent
Phase 22021-11-08
Terminated177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma
Medulloblastoma, Childhood
Phase 1 / Phase 22021-09-30
TerminatedSafety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
SCLC
Phase 1 / Phase 22021-08-17
TerminatedStudy of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/R
Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers
Phase 1 / Phase 22019-02-22
Terminated131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Neuroblastoma, CNS Metastases, Leptomeningeal Metastases
Phase 2 / Phase 32018-12-11
RecruitingNaxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salva
Neuroblastoma
Phase 22018-04-03
CompletedConvection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Prev
Brain Cancer, Brain Stem Glioma
Phase 12011-12-01
TerminatedIntraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum
Peritoneal Cancer
Phase 12010-04-01
TerminatedRadiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
Phase 12004-02-05